Risk-reduction mastectomy: Clinical issues and research needs

Michael Stefanek, Lynn Hartmann, Wendy Nelson

Research output: Contribution to journalReview article

52 Scopus citations

Abstract

Risk-reduction mastectomy (RRM), also known as bilateral prophylactic mastectomy, is a controversial clinical option for women who are at increased risk of breast cancer. High-risk women, including women with a strong family history of breast cancer and BRCA1/2 mutation carriers, have several clinical options: risk-reduction surgery (bilateral mastectomy and bilateral oophorectomy), surveillance (mammography, clinical breast examination, and breast self-examination), and chemoprevention (tamoxifen). We review research in a number of areas central to our understanding of RRM, including recent data on 1) the effectiveness of RRM in reducing breast cancer risk, 2) the perception of RRM among women at increased risk and health-care providers, 3) the decision-making process for follow-up care of women at high risk, and 4) satisfaction and psychological status after surgery. We suggest areas of future research to better guide high-risk women and their health-care providers in the decision-making process.

Original languageEnglish (US)
Pages (from-to)1297-1306
Number of pages10
JournalJournal of the National Cancer Institute
Volume93
Issue number17
StatePublished - Sep 5 2001

    Fingerprint

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Stefanek, M., Hartmann, L., & Nelson, W. (2001). Risk-reduction mastectomy: Clinical issues and research needs. Journal of the National Cancer Institute, 93(17), 1297-1306.